July 13, 2022

Pharmacists Can Now Prescribe Paxlovid With Certain Limitations

The FDA has revised the emergency use authorization for Paxlovid (nirmatrelvir and ritonavir) so that state-licensed pharmacists can prescribe the oral antiviral to eligible patients after the American Pharmacists Association and other key pharmacy groups pushed hard for the change. The requirements and limitations are extensive, however. Learn more about who is eligible to prescribe and in what circumstances.


CDC Urges Pharmacies to Provide More Pediatric COVID-19 Vaccines

Most counties in the United States have had no pediatric clinics, family medicine clinics, or federally qualified health centers providing COVID-19 vaccines to children aged 5 to 11 years; however, nearly 70% have a pharmacy where children can get their shots. A new CDC study urges more interaction between pharmacists and parents to improve uptake, which remains low. Read more.

Noradrenergic Drugs Show Some Promise for Alzheimer's Disease

Drugs commonly used for attention-deficit\hyperactivity disorder, depression, hypertension, and other conditions might be effective for some symptoms of Alzheimer's disease, a new study suggested. The researchers focused on the noradrenergic system, which is disrupted early in Alzheimer's disease, and the drugs that affect its function. Learn more about what researchers have to say.


Vitamin D Supplementation During Pregnancy Reduces Infant Eczema Risks

Pharmacists should not be surprised to get more questions from pregnant women about the benefits of vitamin D supplementation. A recent clinical trial found that infants were less likely to have atopic eczema if their mothers supplemented with 1,000 international units of vitamin D daily from when they were 14 weeks pregnant until they delivered. Read more.

Facebook   Twitter   USP Google App   USP itunes App
U.S. Pharmacist
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Advertisement Advertisement